Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Device Products	6.67B	6.60B	7.01B	6.83B	6.52B
Blood Management Products	995.11M	876.78M	1.04B	1.10B	976.86M
Eliminations	-94.07M	-88.05M	-45.80M	-50.80M	-109.00K
Orthopaedic Products	1.52B	1.44B	1.27B	2.04B	2.13B
Pharma Packaging Products	2.29B	2.28B	2.02B	2.11B	2.04B
Interventional Products	2.01B	1.98B	1.93B	1.73B	1.54B
Total	13.39B	13.09B	13.23B	13.75B	13.21B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
People's Republic of China (PRC)	9.82B	9.80B	10.20B	10.58B	10.55B
United States	1.45B	1.40B	1.30B	1.27B	1.15B
Asia and Others	-	-	1.01B	-	-
Europe, The Middle East and Africa	983.23M	850.89M	709.69M	563.22M	501.92M
Other	1.14B	1.03B	-	1.33B	1.01B
Total	13.39B	13.09B	13.23B	13.75B	13.21B

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error